Table 3 Logistic regression analysis for the presence of HF
From: Association of serum Asprosin concentrations with heart failure
Simple regression | Multiple regression | ||||
|---|---|---|---|---|---|
OR(95%CI) | P | OR(95%CI) | P | ||
Asprosin (ng/L) | 1.008(1.006–1.010) | <0.05 | 1.010(1.003–1.018) | <0.05 | |
NT-ProBNP (ng/L) | 1.015(1.008–1.032) | <0.05 | - | - | |
TC (mmol/L) | 0.327(0.229–0.467) | <0.05 | - | - | |
TG (mmol/L) | 0.446(0.283–0.703) | <0.05 | - | - | |
HDL-c (mmol/L) | 0.036(0.010–0.128) | <0.05 | - | - | |
LDL-c (mmol/L) | 0.289(0.181–0.460) | <0.05 | - | - | |
Apo A1 (g/L) | 0.003(0.000-0.017) | <0.05 | - | - | |
Apo B (g/L) | 0.188(0.065–0.541) | <0.05 | - | - | |
BUN (mmol/L) | 1.826(1.480–2.252) | <0.05 | - | - | |
Cr (µmol/L) | 1.071(1.047–1.096) | <0.05 | - | - | |
FBG (mmol/L) | 1.703(1.303–2.225) | <0.05 | - | - | |
HbA1C (%) | 1.569(1.203–2.046) | <0.05 | - | - | |
LVEF (%) | 0.432(0.325–0.575) | <0.05 | 0.614(0.439–0.860) | <0.05 | |
IVS (mm) | 1.753(1.379–2.230) | <0.05 | - | - | |
LVPW (mm) | 1.832(1.386–2.422) | <0.05 | - | - | |
LAD (mm) | 1.370(1.259–1.491) | <0.05 | - | - | |
LVEDD (mm) | 1.197(1.128–1.271) | <0.05 | - | - | |
Gender (M/F) | 1.808(1.038–3.150) | <0.05 | - | - | |
Age (years) | 1.118(1.084–1.152) | <0.05 | 1.058(1.004–1.665) | <0.05 | |
No CAD | 0.012(0.005–0.032) | <0.05 | 0.019(0.001–0.313) | <0.05 | |
No DM | 0.192(0.093–0.393) | <0.05 | - | - | |